Researchers at Massachusetts General Hospital have developed a microfluidics chip that captures rare cancer cells in numbers that are high enough to enable analysis for molecular markers, reports Technology Review's Emily Singer. The device could save patients the hassle and pain of tumor biopsies since a sufficient number of cells could be culled from the bloodstream, and doctors could pick better drugs for their patients by doing the molecular marker analysis, she adds.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.